A non–RGD-based integrin binding peptide (ATN-161) blocks breast cancer growth and metastasis in vivo
Khalili, Parisa, Arakelian, Ani, Chen, Gaoping, Plunkett, Marian L, Beck, Ivy, Parry, Graham C, Doñate, Fernando, Shaw, David E, Mazar, Andrew P, Rabbani, Shafaat A
Published in Molecular cancer therapeutics (01.09.2006)
Published in Molecular cancer therapeutics (01.09.2006)
Get full text
Journal Article
Pharmacology of the Novel Antiangiogenic Peptide ATN-161 (Ac-PHSCN-NH2): Observation of a U-Shaped Dose-Response Curve in Several Preclinical Models of Angiogenesis and Tumor Growth
DONATE, Fernando, PARRY, Graham C, KERBEL, Robert S, MAZAR, Andrew P, SHAKED, Yuval, HENSLEY, Harvey, XIAOJUN GUAN, BECK, Ivy, TEL-TSUR, Ziva, PLUNKETT, Marian L, MANUIA, Mari, SHAW, David E
Published in Clinical cancer research (01.04.2008)
Published in Clinical cancer research (01.04.2008)
Get full text
Journal Article
Peptides derived from the histidine-proline domain of the histidine-proline-rich glycoprotein bind to tropomyosin and have antiangiogenic and antitumor activities
DONATE, Fernando, JUAREZ, Jose C, XIAOJUN GUAN, SHIPULINA, Natalya V, PLUNKETT, Marian L, TEL-TSUR, Ziva, SHAW, David E, MORGAN, William T, MAZAR, Andrew P
Published in Cancer research (Chicago, Ill.) (15.08.2004)
Published in Cancer research (Chicago, Ill.) (15.08.2004)
Get full text
Journal Article
Angiogenesis blockade as a new therapeutic approach to experimental colitis
Danese, Silvio, Sans, Miquel, Spencer, David M, Beck, Ivy, Doñate, Fernando, Plunkett, Marian L, de la Motte, Carol, Redline, Raymond, Shaw, David E, Levine, Alan D, Mazar, Andrew P, Fiocchi, Claudio
Published in Gut (01.06.2007)
Published in Gut (01.06.2007)
Get full text
Journal Article
Histidine-proline-rich glycoprotein has potent antiangiogenic activity mediated through the histidine-proline-rich domain
JUAREZ, Jose C, XIAOJUN GUAN, MORGAN, William T, DONATE, Fernando, SHIPULINA, Natalya V, PLUNKETT, Marian L, PARRY, Graham C, SHAW, David Elliot, ZHANG, Jing-Chuan, RABBANI, Shafaat A, MCCRAE, Keith R, MAZAR, Andrew P
Published in Cancer research (Chicago, Ill.) (15.09.2002)
Get full text
Published in Cancer research (Chicago, Ill.) (15.09.2002)
Journal Article
The T lymphocyte glycoprotein CD2 binds the cell surface ligand LFA-3
Selvaraj, P, Plunkett, M L, Dustin, M, Sanders, M E, Shaw, S, Springer, T A
Published in Nature (London) (26.03.1987)
Published in Nature (London) (26.03.1987)
Get more information
Journal Article
Calcium alginate beads as a slow-release system for delivering angiogenic molecules in vivo and in vitro
Downs, E C, Robertson, N E, Riss, T L, Plunkett, M L
Published in Journal of cellular physiology (01.08.1992)
Published in Journal of cellular physiology (01.08.1992)
Get more information
Journal Article
A quantitative in vivo mouse model used to assay inhibitors of tumor-induced angiogenesis
ROBERTSON, N. E, DISCAFANI, C. M, DOWNS, E. C, HAILEY, J. A, SARRE, O, RUNKLE, R. L, POPPER, T. L, PLUNKETT, M. L
Published in Cancer research (Chicago, Ill.) (15.02.1991)
Get full text
Published in Cancer research (Chicago, Ill.) (15.02.1991)
Journal Article
HISTIDINE PROLINE RICH GLYCOPROTEIN (HPRG) AS AN ANTI-ANGIOGENIC AND ANTI-TUMOR AGENT
HARRIS, SCOTT, DONATE, FERNANDO, PLUNKETT, MARIAN, L, MAZAR, ANDREW, P
Year of Publication 08.09.2004
Get full text
Year of Publication 08.09.2004
Patent
HISTIDINE PROLINE RICH GLYCOPROTEIN (HPRG) AS AN ANTI-ANGIOGENIC AND ANTI-TUMOR AGENT
HARRIS, SCOTT, DONATE, FERNANDO, PLUNKETT, MARIAN, L, MAZAR, ANDREW, P
Year of Publication 03.12.2003
Get full text
Year of Publication 03.12.2003
Patent
HISTIDINE PROLINE RICH GLYCOPROTEIN (HPRG) AS AN ANTI-ANGIOGENIC AND ANTI-TUMOR AGENT
HARRIS, SCOTT, DONATE, FERNANDO, PLUNKETT, MARIAN, L, MAZAR, ANDREW, P
Year of Publication 30.05.2003
Get full text
Year of Publication 30.05.2003
Patent
HISTIDINE PROLINE RICH GLYCOPROTEIN (HPRG) AS AN ANTI-ANGIOGENIC AND ANTI-TUMOR AGENT
HARRIS, SCOTT, DONATE, FERNANDO, PLUNKETT, MARIAN, L, MAZAR, ANDREW, P
Year of Publication 22.08.2002
Get full text
Year of Publication 22.08.2002
Patent